Effect of fidarestat and α-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction

Experimental Diabesity Research

Volumn 5, Issue 2, 2004, Pages 123-135

  Yorek, Mark A ^a   Coppey, L J ^a   Gellett, J S ^a   Davidson, E P ^a   Lund, D D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Lipoic acid; Acetylcholine; Aldose reductase; Diabetes; Diabetic neuropathy; Endothelium; Fidarestat; Oxygen radicals; Vasodilation

Indexed keywords

ACETYLCHOLINE; ALDOSE REDUCTASE INHIBITOR; DIHYDROLIPOATE; FIDARESTAT; STREPTOZOCIN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD FLOW; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; ENDONEURIUM; MALE; MONOTHERAPY; MOTOR NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARTERIOLES; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FRUCTOSE; GLUTATHIONE; IMIDAZOLIDINES; INOSITOL; LENS, CRYSTALLINE; MALE; MOTOR NEURONS; NEURAL CONDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SORBITOL; SUPEROXIDES; THIOCTIC ACID;

EID: 3042847281     PISSN: 15438600     EISSN: None     Source Type: Journal    
DOI: 10.1080/15438600490277824     Document Type: Article

References (54)

1. Tomlinson, D. (1998) Future prevention and treatment of diabetic neuropathy. Diabetes Metab., 24, 79-83.
2. Akbari, C. M., and LoGerfo, F. W. (1999) Diabetes and peripheral vascular disease. J. Vasc. Surg., 30, 373-384.
3. Baynes, J. W., and Thorpe, S. R. (1999) Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes, 48, 1-9.
4. De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., and Vanhoutte, P. M. (2000) Endothelial dysfunction in diabetes. Br. J. Pharmacol., 130, 963-974.
5. Pieper, G. M., Langenstroer, P., and Gross, G. J. (1993) Hydroxyl radicals mediate injury to endothelium-dependent relaxation in diabetic rat. Mol. Cell. Biochem., 122, 139-145.
6. Cameron, N. E., and Cotter, M. A. (1995) Neurovascular dysfunction in diabetic rats: Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J. Clin. Invest., 96, 1159-1163.
7. Pieper, G. M., and Siebeneich, W. (1997) Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J. Cardiovasc. Pharmacol., 30, 734-738.
8. Cameron, N. E., Cotter, M. A., Horrobin, D. H., and Tritschler, H. J. (1998) Effects of α-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids. Diabetologia, 41, 390-399.
9. Pieper, G. M., and Siebeneich, W. (1998) Oral administration of the antioxidant N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J. Cardiovasc. Pharmacol., 32, 101-105.
10. Keegan, A., Cotter, M. A., and Cameron, N. E. (1999) Effects of diabetes and treatment with the antioxidant α-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia, 42, 343-350.
11. Obrosova, I. G., Fathallah, L., and Greene, D. A. (2000) Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: Effect of DL-α-lipoic acid. Eur. J. Pharmacol., 398, 139-146.
12. Gocmen, C., Secilmis, A., Kumcu, E. K., Ertug, P. U., Onder, S., Dikmen, A., and Baysal, F. (2000) Effects of vitamin E and sodium selenate on neurogenic and endothelial relaxation of corpus cavernosum in the diabetic mouse. Eur. J. Pharmaccol., 398, 93-98.
13. Cameron, N. E., and Cotter, M. A. (1999) Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 45, 137-146.
14. Cameron, N. E., Cotter, M. A., and Maxfield, E. K. (1993) Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia, 36, 299-304.
15. Cameron, N. E., Cotter, M. A., Archibald, V., Dines, K. C., and Maxfield, E. K. (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia, 37, 449-459.
16. Karasu, C., Dewhurst, M., Stevens, E. J., and Tomlinson, D. R. (1995) Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia, 38, 129-134.
17. Finegold, D., Lattimer, S. A., Nolle, S., Bernstein, M., and Greene, D.A. (1983) Polyol pathway activity and myo-inositol metabolism. Diabetes, 32, 988-992.
18. Mayer, J. H., and Tomlinson, D. R. (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia, 25, 433-438.
19. Tomlinson, D. R., Moriaity, R. J., and Heidi Mayer, J. (1984) Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor sorbinil. Diabetes, 33, 470-476.
20. Kikkawa, R., Hatanaka, I., Yasuda, H., Kobayashi, N., and Shigeta, Y. (1984) Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats. Metabolism, 33, 212-214.
21. Sima, A. A. F., Prashar, A., Zhang, W.-X., Chakrabarti, S., and Greene, D. A. (1990) Preventive effect of long-term aldose reductase inhibition (Ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic bio-breeding rat. J. Clin. Invest., 85, 1410-1420.
22. Cameron, N. E., Cotter, M. A., Dines, K. C., Maxfield, E. K., Carey, F., and Mirrlees, D. J. (1994) Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism. Diabetologia, 37, 651-663.
23. Hirata, Y., Fujimori, S., and Okada, K. (1988) Effect of a new aldose reductase inhibitor, 8′-chloro-2′,3′-dihydrospiro-pyrrolidine-3,6′ (5′H) -pyrrolol[1,2,3-de][1,4]benzoxamine]-2, 5,5′-trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats. Metabolism, 37, 159-163.
24. Yoshida, T., Nishioka, H., Yoshioka, K., Nakano, K., Kondo, M., and Terashima, H. (1987) Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system nerve disorders in STZ-induced diabetic rats. Diabetes, 36, 6-13.
25. Betteridge, D. J. (2000) What is oxidative stress? Metabolism, 49, 3-8.
26. Shackelford, R. E., Kaufmann, W. K., and Paules, R. S. (2000) Oxidative stress and cell cycle checkpoint function. Free Radic. Biol. Med., 28, 1387-1404.
27. Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., and Maher, P. (1998) Cellular mechanisms of resistance to chronic oxidative stress. Free Radic. Biol. Med., 24, 1375-1389.
28. Terata, K., Coppey, L. J., Davidson, E. P., Dunlap, J. A., Gutterman, D. D., and Yorek, M. A. (1999) Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br. J. Pharmacol., 128, 837-843.
29. Coppey, L. J., Davidson, E. P., Dunlap, J. A., Lund, D. D., and Yorek, M. A. (2000) Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int. J. Exp. Diabetes Res., 1, 131-143.
30. Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., and Yorek, M. A. (2001) Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 50, 1927-1937.
31. Otter, D. J., and Chess-Williams, R. (1994) The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetes rats. Br. J. Pharmacol., 113, 576-580.
32. 2) synthesis by aortic rings from rats with streptozotocin-induced diabetes. Prostaglandins Leukot. Essent. Fatty Acids, 44, 233-236.
33. Cameron, N. E., and Cotter, M. A. (1992) Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: Role of polyol pathway. Diabetologia, 35, 1011-1019.
34. Keegan, A., Jack, A.M., Cotter, M.A., and Cameron, N.E. (2000) Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats. J. Cardiovasc. Pharmacol., 35, 606-613.
35. Coleman, M. D., Eason, R. C., and Bailey, C. J. (2001) The therapeutic use of lipoic acid in diabetes: A current perspective. Environ. Toxicol. Pharmacol., 10, 167-172.
36. Packer, L., Kraemer, K., and Rimbach, G. (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition, 17, 888-895.
37. Dincer, Y., Telci, A., Kayah, R., Yilmaz, I.A., Cakatay, U., and Akcay, T. (2002) Effect of α-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats. Clin. Exp. Pharmacol. Physiol., 29, 281-284.
38. Jones, W., Li, X., Zhi-Chao, Q., Perriott, L., Whitesell, R. R., and May, J. M. (2002) Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells. Free Radic. Biol. Med., 33, 83-93.
39. Haramaki, N., Han, D., Handelman, G. J., Tritschler, H. J., and Packer, L. (1997) Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid. Free Radic. Biol. Med., 22, 535-542.
40. Bravenboer, B., Kappelle, A. C., Hamers, F. P. T., van Buren, T., Erkelens, D. W., and Gispen, W. H. (1992) Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia, 35, 813-817.
41. van Dam, P. S. (2002) Oxidative stress and diabetic neuropathy: Pathophysiological mechanisms and treatment perspectives. Diabetes Metab. Res. Rev., 18, 176-184.
42. 2 clearance measurement of blood flow: A review of technique and polarographic principles. Stroke, 11, 552-564.
43. Lou, M. F., Dickerson, J. E., Jr., Garadi, R., and York, B. M. Jr. (1988) Glutathione depletion in the lens of galactosemic and diabetic rats. Exp. Eye Res., 46, 517-530.
44. Mihara, M., Uchiyama, M., and Fukuzama, K. (1980) Thiobarbituric acid value of fresh homogenate of rat as a parameter of lipid peroxidation in aging, CC14 intoxication, and vitamin E deficiency. Biochem. Med. 23, 302-311.
45. Siman, C. M., and Eriksson, U. J. (1997) Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia, 40, 1416-1424.
46. Teichert, J., and Priess, R. (2002) High-performance liquid chromatographic assay for α-lipoic acid and five of its metabolites in human plasma and urine. J. Chromatog., 769, 269-281.
47. Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., and Yorek, M. A. (2002) Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Int. J. Exp. Diabetes Res., 3, 21-36.
48. Arner, E. S., Nordberg, J., and Holmgren, A. (1996) Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem. Biophysical Res. Commun., 225, 268-274.
49. Constantinescu, A., Pick, U., Handelman, G. J., Haramaki, N., Han, D., Podda, M., Tritschler, H. J., and Packer, L. (1995) Reduction and transport of lipoic acid by human erythrocytes. Biochem. Pharmacol., 50, 253-261.
50. Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., van den Enden, M., Kilo, C., and Tilton, R. G. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes, 42, 801-813.
51. Nakamura, J., Hamada, Y., Chaya, S., Nakashima, E., Naruse, K., Kato, K., Yasuda, Y., Kamiya, H., Sakakibara, F., Koh, N., and Hotta, N. (2002) Transition metals and polyol pathway in the development of diabetic neuropathy in rats. Diabetes Metab. Res. Rev., 18, 395-402.
52. Stevens, M. J., Obrosova, I., Cao, X., Van Huysen, C., and Greene, D. A. (2000) Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes, 49, 1006-1015.
53. Keegan, A., Cotter, M. A., and Cameron, N. E. (2001) Corpus cavernosum dysfunction in diabetic rats: Effects of combined alpha-lipoic acid and gamma-linolenic acid treatment. Diabetes Metab. Res. Rev., 17, 380-386.
54. Cotter, M. A., Mirrlees, D. J., and Cameron, N. E. (2001) Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats. Eur. J. Pharmacol., 417, 223-230.